Linc00665 Can Predict the Response to Cisplatin-Paclitaxel Neoadjuvant Chemotherapy for Breast Cancer Patients

OBJECTIVE: Linc00665 is a novel long non-coding RNA that can promote the progression of breast cancer, but its value in predicting the efficacy of neoadjuvant chemotherapy (NAC) for breast cancer has not been reported. We aim to analyze the correlation between Linc00665 expression and pathological c...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Huijuan, Sheng, Xiaonan, Sha, Rui, Peng, Jing, Yang, Fan, Zhou, Liheng, Lin, Yanping, Xu, Yaqian, Zhang, Shan, Yin, Wenjin, Lu, Jinsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961084/
https://www.ncbi.nlm.nih.gov/pubmed/33738251
http://dx.doi.org/10.3389/fonc.2021.604319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961084/
https://www.ncbi.nlm.nih.gov/pubmed/33738251
http://dx.doi.org/10.3389/fonc.2021.604319

Ejemplares similares